Climb Biotherapeutics, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Climb Biotherapeutics, Inc. (CLYM) — Frequently Asked Questions

Climb Biotherapeutics, Inc. (CLYM) is a publicly traded US company. Explore CLYM's stock price, financial statements, earnings history, margins and key ratios below.

What is the CLYM stock price?

CLYM trades at $10.80 (-3.01% on the day).